Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy

被引：1
|
作者：
Chiba, Mitsuro [1 ]
Ishii, Hajime [1 ]
Sageshima, Masato [2 ]
Iwabuchi, Akira [3 ]
机构：
[1] Akita City Hosp, Div Gastroenterol, 4-30 Matsuoka Machi, Akita 0100933, Japan
[2] Akita City Hosp, Div Pathol, Akita, Japan
[3] Iwabuchi Internal Med Gastroenterol Clin, Akita, Japan
来源：
INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷 / 11期
关键词：
DISEASE;
D O I：
10.1093/ibd/izab168
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Appendiceal orifice inflammation, which is often observed in mild or moderate distal ulcerative colitis, was observed in a case of severe UC. Appendiceal orifice inflammation resolved after new induction therapy for severe UC: infliximab and a plant-based diet as first-line therapy.
引用
收藏
页码：E138 / E139
页数：2
相关论文
共 50 条
  • [1] Promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy
    Chiba, Mitsuro
    Kimura, Kazuya
    [J]. JOURNAL OF GASTROENTEROLOGY, 2024, 59 (07) : 641 - 642
  • [2] promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy
    Naganuma, Makoto
    [J]. JOURNAL OF GASTROENTEROLOGY, 2024, 59 (07) : 643 - 643
  • [3] Induction with infliximab and a plant-based diet as first-line (IPF) therapy for moderate-to-severe to severe ulcerative colitis
    Chiba, Mitsuro
    Nakane, Kunio
    Tsuji, Tsuyotoshi
    Tsuda, Satoko
    Ishii, Hajime
    Ohno, Hideo
    Watanabe, Kenta
    Ito, Mai
    Obara, Yu
    Komatsu, Masafumi
    Sugawara, Takeshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 483 - 483
  • [4] Infliximab and Plant-Based Diet as First-Line Therapy Followed by Corticosteroid Therapy for Severe Ulcerative Colitis: A Case Report
    Chiba, Mitsuro
    Tsuji, Tsuyotoshi
    Masai, Rie
    Odashima, Masaru
    Sageshima, Masato
    [J]. GASTROINTESTINAL DISORDERS, 2022, 4 (04): : 230 - 236
  • [5] COST-EFFECTIVENESS OF VEDOLIZUMAB, INFLIXIMAB, AND ADALIMUMAB AS FIRST-LINE THERAPY FOR ULCERATIVE COLITIS
    Beilman, Candace L.
    Fedorak, Richard N.
    Halloran, Brendan P.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S450 - S450
  • [6] Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis
    Yokomizo, Lauren
    Limketkai, Berkeley
    Park, K. T.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2016, 3 (01):
  • [7] Induction of remission with combined infliximab and plant-based diet as the first-line therapy in Crohn's disease: No failure in 42 consecutive cases
    Chiba, Mitsuro
    Tsuji, Tsuyotoshi
    Sugawara, Kae
    Ohno, Hideo
    Ishii, Hajime
    Tsuda, Satoko
    Koh, Mai
    Watanabe, Kenta
    Sakai, Toshitaka
    Nakane, Kunio
    Komatsu, Masafumi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 37 - 37
  • [8] Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: Relation to medical therapy and disease extent
    Yang, SK
    Jung, HY
    Cho, BD
    Nam, SW
    Shim, KN
    Park, ER
    Hong, WS
    Min, YI
    [J]. GASTROINTESTINAL ENDOSCOPY, 1998, 47 (04) : AB107 - AB107
  • [9] Enhancement of long-term relapse-free rate by infliximab and plant-based diet as first-line (IPF) therapy in Crohn disease
    Chiba, Mitsuro
    Tsuji, Tsuyotoshi
    Obara, Yu
    Ohno, Hideo
    Ishii, Hajime
    Tsuda, Satoko
    Nakane, Kunio
    Komatsu, Masafumi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 303 - 303
  • [10] Comparative Effectiveness of First-Line Infliximab and Vedolizumab in Patients with Early Ulcerative Colitis
    Hemed, A. Rozenfeld
    Cohen, N. A.
    Green, O.
    Hirsch, A.
    Thurm, T.
    Ron, Y.
    Fishman, S.
    Leibovitzh, H.
    Maharshak, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1476 - I1477
12345